From: The U.S. Department of Health & Human Services http://healthfinder.gov/news/newsstory.asp?docID=601118

Diabetes - Type 1
This 13-month clinical trial is for people between the ages of 18 and 80 who have type 1 diabetes. The study will evaluate an inhaled insulin product that is not yet approved by the U.S. Food and Drug Administration (FDA). The treatment period is one year (12 visits), with a followup visit in the subsequent month.
The research sites are located across the United States.
More information
Please see http://www.centerwatch.com/patient/studies/cat602.html.